<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_PCB523E">Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial</title>
				<funder>
					<orgName type="full">LDI&apos;s Center for Health Incentives and Behavioral Economics</orgName>
				</funder>
				<funder>
					<orgName type="full">Leonard Davis Institute</orgName>
					<orgName type="abbreviated">LDI</orgName>
				</funder>
				<funder>
					<orgName type="full">Sharpe</orgName>
				</funder>
				<funder>
					<orgName type="full">Merck</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100004334</idno>
				</funder>
				<funder>
					<orgName type="full">CVS Caremark</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">ª 2016 by the National Kidney Foundation, Inc. Ó 2016 by the National Kidney Foundation, Inc.</p>
				</availability>
				<date type="published" when="2016-12-07">December 7, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MD, MSCE</roleName><forename type="first">Peter</forename><forename type="middle">P</forename><surname>Reese</surname></persName>
							<email>peter.reese@uphs.upenn.edu</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Renal</note>
								<orgName type="laboratory">Renal</orgName>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Biostatistics and Epidemiology , and</note>
								<orgName type="department">Department of Biostatistics and Epidemiology</orgName>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Center for Clinical Epidemiology and Biostatistics , Perelman School of Medicine at the University of Pennsylvania ;</note>
								<orgName type="department" key="dep1">Center for Clinical Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Roy</forename><forename type="middle">D</forename><surname>Bloom</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Renal</note>
								<orgName type="laboratory">Renal</orgName>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Leonard Davis Institute Center for Health Incentives and Behavioral Economics , University of Pennsylvania ;</note>
								<orgName type="department">Leonard Davis Institute Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PharmD</roleName><forename type="first">Jennifer</forename><surname>Trofe-Clark</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Renal</note>
								<orgName type="laboratory">Renal</orgName>
							</affiliation>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>5</label> Department of Pharmacy Services , Hospital of the University of Pennsylvania ;</note>
								<orgName type="department">Department of Pharmacy Services</orgName>
								<orgName type="institution">Hospital of the University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MA</roleName><forename type="first">Adam</forename><surname>Mussell</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Center for Clinical Epidemiology and Biostatistics , Perelman School of Medicine at the University of Pennsylvania ;</note>
								<orgName type="department" key="dep1">Center for Clinical Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>BA</roleName><forename type="first">Daniel</forename><surname>Leidy</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Center for Clinical Epidemiology and Biostatistics , Perelman School of Medicine at the University of Pennsylvania ;</note>
								<orgName type="department" key="dep1">Center for Clinical Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>BS</roleName><forename type="first">Simona</forename><surname>Levsky</surname></persName>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>6</label> School of Arts and Sciences , University of Pennsylvania ;</note>
								<orgName type="department">School of Arts and Sciences</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MS, MBA</roleName><forename type="first">Jingsan</forename><surname>Zhu</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Leonard Davis Institute Center for Health Incentives and Behavioral Economics , University of Pennsylvania ;</note>
								<orgName type="department">Leonard Davis Institute Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Lin</forename><surname>Yang</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Leonard Davis Institute Center for Health Incentives and Behavioral Economics , University of Pennsylvania ;</note>
								<orgName type="department">Leonard Davis Institute Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Wenli</forename><surname>Wang</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Leonard Davis Institute Center for Health Incentives and Behavioral Economics , University of Pennsylvania ;</note>
								<orgName type="department">Leonard Davis Institute Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>ScD</roleName><forename type="first">Andrea</forename><surname>Troxel</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Biostatistics and Epidemiology , and</note>
								<orgName type="department">Department of Biostatistics and Epidemiology</orgName>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Center for Clinical Epidemiology and Biostatistics , Perelman School of Medicine at the University of Pennsylvania ;</note>
								<orgName type="department" key="dep1">Center for Clinical Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Leonard Davis Institute Center for Health Incentives and Behavioral Economics , University of Pennsylvania ;</note>
								<orgName type="department">Leonard Davis Institute Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MSCE</roleName><forename type="first">Harold</forename><forename type="middle">I</forename><surname>Feldman</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Renal</note>
								<orgName type="laboratory">Renal</orgName>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Biostatistics and Epidemiology , and</note>
								<orgName type="department">Department of Biostatistics and Epidemiology</orgName>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Center for Clinical Epidemiology and Biostatistics , Perelman School of Medicine at the University of Pennsylvania ;</note>
								<orgName type="department" key="dep1">Center for Clinical Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Kevin</forename><surname>Volpp</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Leonard Davis Institute Center for Health Incentives and Behavioral Economics , University of Pennsylvania ;</note>
								<orgName type="department">Leonard Davis Institute Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
							<affiliation key="aff6">
								<note type="raw_affiliation"><label>7</label> Department of Medicine and Medical Ethics and Health Policy , Perelman School of Medicine ;</note>
								<orgName type="department">Department of Medicine and Medical Ethics and Health Policy</orgName>
								<orgName type="institution">Perelman School of Medicine</orgName>
							</affiliation>
							<affiliation key="aff7">
								<note type="raw_affiliation"><label>8</label> Department of Health Care Management , Wharton School , University of Pennsylvania ; and</note>
								<orgName type="department" key="dep1">Department of Health Care Management</orgName>
								<orgName type="department" key="dep2">Wharton School</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
							</affiliation>
							<affiliation key="aff8">
								<note type="raw_affiliation"><label>9</label> Center for Health Equity Research and Promotion , Cresencz Philadelphia Veterans Affairs Medical Center , Philadelphia , PA. Blockley Hall ,</note>
								<orgName type="department">Center for Health Equity Research and Promotion</orgName>
								<orgName type="laboratory">Blockley Hall</orgName>
								<orgName type="institution">Cresencz Philadelphia Veterans Affairs Medical Center</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<note type="raw_affiliation">Center for Clinical Epidemiology and Biostatistics , University of Pennsylvania , 423 Guardian Dr , Philadelphia , PA 19104.</note>
								<orgName type="department">Center for Clinical Epidemiology and Biostatistics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<addrLine>423 Guardian Dr</addrLine>
									<postCode>19104.</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_FRZaAEH">Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-12-07">December 7, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">801E070C8DE5CB953238EF84214BF736</idno>
					<idno type="DOI">10.1053/j.ajkd.2016.10.017</idno>
					<note type="submission">Received March 27, 2016. Accepted in revised form October 10, 2016. Originally</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T05:37+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_N79ywFu">Kidney transplantation</term>
					<term xml:id="_c7fb74Y">kidney transplant recipient (KTR)</term>
					<term xml:id="_Q7snDZG">immunosuppression</term>
					<term xml:id="_H39yBM3">tacrolimus</term>
					<term xml:id="_6Y7dzq5">behavior change</term>
					<term xml:id="_qxRBuWK">adherence</term>
					<term xml:id="_fEh3rP8">compliance</term>
					<term xml:id="_2gTTyC6">automated reminder</term>
					<term xml:id="_Hv24bjF">medication reminder</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_Su6R4Rb"><p xml:id="_jZXK7ht"><s xml:id="_TRXMemX">Background: Immunosuppression nonadherence increases the risk for kidney transplant loss after transplantation.</s><s xml:id="_gDGfXgq">Wireless-enabled pill bottles have created the opportunity to monitor medication adherence in real time.</s><s xml:id="_EhVNJ8S">Reminders may help patients with poor memory or organization.</s><s xml:id="_Wv3pvwR">Provision of adherence data to providers may motivate patients to improve adherence and help providers identify adherence barriers.</s></p><p xml:id="_sBgY7P2"><s xml:id="_23HGht9">Study Design: Randomized controlled trial.</s></p><p xml:id="_akDrh2E"><s xml:id="_tuaJnrw">Setting &amp; Participants: Kidney transplant recipients (n 5 120) at a single center.</s></p><p xml:id="_GZFsV9n"><s xml:id="_yJeVnse">Intervention: Participants were provided wireless pill bottles to store tacrolimus and record bottle openings.</s><s xml:id="_ewT6PhN">Participants were randomly assigned 1:1:1 to adherence monitoring with customized reminders (including alarms, texts, telephone calls, and/or e-mails), monitoring with customized reminders plus provider notification (every 2 weeks, providers received notification if adherence decreased to ,90% during that period), or wireless pill bottle use alone (control).</s></p><p xml:id="_TVm2bDD"><s xml:id="_NPBvmud">Outcomes: The main outcome was bottle-measured tacrolimus adherence during the last 90 days of the 180-day trial.</s><s xml:id="_bEDuU4n">A secondary outcome was tacrolimus whole-blood concentrations at routine clinical visits.</s></p><p xml:id="_ASXJV8f"><s xml:id="_3MQbPgn">Measurements: Adherence for the primary outcome was assessed via wireless pill bottle openings.</s></p><p xml:id="_ZZucCgw"><s xml:id="_VzS9XzR">Results: Mean participant age was 50 years; 60% were men, and 40% were black.</s><s xml:id="_jnPPc92">Mean adherence was 78%, 88%, and 55% in the reminders, reminders-plus-notification, and control arms (P , 0.001 for comparison of each intervention to control).</s><s xml:id="_5e9d7uS">Mean tacrolimus levels were not significantly different between groups.</s></p><p xml:id="_ZbAYRA9"><s xml:id="_seMuG3j">Limitations: The study did not assess clinical end points.</s><s xml:id="_eX94quj">Participants and study coordinators were not blinded to intervention arm.</s></p><p xml:id="_6HQNn43"><s xml:id="_yxEuTDZ">Conclusions: Provider notification and customized reminders appear promising in helping patients achieve better medication adherence, but these strategies require evaluation in trials powered to detect differences in clinical outcomes.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_65B2aVn"><p xml:id="_DMhenJK"><s xml:id="_M3EETDW">or costs. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref></s><s xml:id="_qmgNjM4">6]<ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref> Taken together, these findings demonstrate the need to develop and test scalable strategies to improve adherence. <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref></s><s xml:id="_vMRYWb6">0]<ref type="bibr" target="#b10">[11]</ref> Given the interdisciplinary nature of transplant care, such strategies might involve physicians and other team members, such as pharmacists or clinical coordinators. <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13</ref></s><s xml:id="_a7cpcmj">nsights from studies of adherence and behavioral economic theory suggest new methods to overcome adherence barriers in transplantation. <ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref></s><s xml:id="_K6qBcK9">5]<ref type="bibr" target="#b15">[16]</ref> First, sustaining behaviors such as medication adherence often requires repeated concrete feedback to help the patient stay engaged. <ref type="bibr" target="#b16">17</ref></s><s xml:id="_fnsHgVv">Unfortunately, adherence to immunosuppression creates adverse effects, but does not make patients feel better because early rejection does not usually lead to symptoms.</s><s xml:id="_bq8j7Mc">Reminders or repeated incentives may be effective in keeping patients focused on the importance of immunosuppression adherence to future health.</s><s xml:id="_62AjUYY">Second, physicians often overestimate their patients' medication adherence. <ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref></s><s xml:id="_XpzpxGd">]<ref type="bibr" target="#b19">[20]</ref> Early notification to the health care team about nonadherence might enable providers to overcome patients' concerns about adverse effects or clarify misunderstandings about dosing.</s><s xml:id="_Wqdszbs">Providers can also schedule appointments at shorter intervals, refer patients to specialists such as a pharmacist, or direct patients to social support when financial barriers exist.</s><s xml:id="_GUBCvAY">Third, social forces may influence individual behavior. <ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref></s><s xml:id="_rxuZSCV">2]<ref type="bibr" target="#b22">[23]</ref> Specifically, patients may desire to avoid disapproval from their physicians related to medication nonadherence.</s><s xml:id="_VRCkzrY">In transplantation, immunosuppression nonadherence can be stigmatized by health care staff and even patients' families because kidney transplant recipients are stewards of a precious gift-the organ. <ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25</ref></s><s xml:id="_GpQSrMY">Therefore, real-time monitoring of medication adherence by physicians and other transplantation providers may create a "social incentive" for patients to comply with their immunosuppression regimens. <ref type="bibr" target="#b14">15</ref></s><s xml:id="_HdVARD7">ireless technology has created opportunities to estimate pill-taking behavior in real time, supplemented by customizable visual and audible alarms, texts, telephone calls, and e-mails when a dose is due.</s><s xml:id="_7zvpttg">To our knowledge, real-time provider notification of low adherence using wireless pill bottles has not previously been tested.</s><s xml:id="_nfP7Zpx">However, directly observed therapy-either in person or using video-has been widely implemented in tuberculosis and human immunodeficiency virus (HIV) treatment, with some successful trials, particularly when there is flexibility about who receives the adherence report. <ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref></s><s xml:id="_w7szM9N">7]<ref type="bibr" target="#b27">[28]</ref> Additionally, interventions that alert physicians when patients do not refill prescriptions have also been tested. <ref type="bibr" target="#b28">29</ref></s><s xml:id="_kbzg6fP">ireless pill bottles also introduce challenges, such as requiring patients to master a new technology and clinical teams to respond to a continuous data stream.</s><s xml:id="_SvzUq5a">However, the transplantation setting usually features a clinical coordinator assigned to each patient who is responsible for helping with many aspects of care.</s><s xml:id="_nbpRtgU">If wireless pill bottles were implemented in the future, these transplantation coordinators could feasibly monitor output from pill bottles and help devise solutions.</s></p><p xml:id="_KvEguFH"><s xml:id="_hKBRZgS">We conducted a randomized controlled trial among new kidney transplant recipients provided with wireless pill bottles to determine whether automated reminders alone or paired with provider notification in cases of low adherence improve tacrolimus adherence compared to adherence monitoring alone.</s><s xml:id="_kXAMSQy">We considered the trial a pilot because of minimal preliminary data about pill bottle2measured adherence in the 6 months posttransplantation.</s><s xml:id="_PqxjT6Y">The primary outcome was the percentage of correctly taken tacrolimus doses as estimated by pill-bottle openings.</s><s xml:id="_CJY2TYw">Given evidence of providers' limited ability to detect nonadherence, a secondary aim was to examine the accuracy of pharmacists' predictions of each participant's adherence during the trial.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_JGFVmgk">METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PTzsYHW">Overview</head><p xml:id="_sA4tx58"><s xml:id="_rRJZvyR">This study trial enrolled 120 kidney transplant recipients or kidney-pancreas recipients at the Hospital of the University of Pennsylvania.</s><s xml:id="_R62VHQh">Each participant was provided with a wireless pill bottle (Vitality GlowCap; Vitality Inc) that recorded pill-cap openings; these data were transmitted in real time to the study database. <ref type="bibr" target="#b29">30</ref></s><s xml:id="_YzKapUV">Participants were instructed to store only tacrolimus in the bottle and refill as necessary.</s><s xml:id="_73h6mG3">Participation lasted 6 months and was approved by the University of Pennsylvania Institutional Review Board (protocol #814788).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_rmAdRSj">Inclusion and Exclusion Criteria</head><p xml:id="_w6r8kFe"><s xml:id="_Vy2EpD2">The study was conducted in adults (aged $18 years) who were taking immediate-release tacrolimus.</s><s xml:id="_X58ny6C">Exclusions included patient inability to manage medications, poor English comprehension (because of the requirement for direct communication with study staff), HIV-positive serostatus (because of drug interactions that often require unusual tacrolimus dosing regimens), <ref type="bibr" target="#b30">31</ref> living more than 120 miles from the center (because these patients return to local care soon after transplantation), and/or discharge to an acute-care facility (where a patient would not personally manage medications).</s><s xml:id="_P2rQeTF">Participants could remain in the trial if prescribed immediaterelease tacrolimus twice a day (usual practice) or a thrice-aday regimen (1 participant).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KbBFbc8">Enrollment</head><p xml:id="_up7g5sW"><s xml:id="_TXF8wnf">Patients were approached for informed consent during the first 2 weeks after transplantation.</s><s xml:id="_3pzMC8K">During enrollment, the study coordinator provided a wireless pill bottle and demonstrated its use.</s><s xml:id="_s3WABFW">Participation lasted for 180 days, including a 2-week initial wash-in period to become accustomed to the wireless device.</s></p><p xml:id="_wQYRdNS"><s xml:id="_WndzcAj">Participants indicated the times when they intended to take tacrolimus.</s><s xml:id="_FVkPR2S">The study coordinator created an account for each participant on the Vitality website and entered these times.</s><s xml:id="_Ub5fcjD">Adherence data were transferred from the Vitality website to a web-based secure research platform called Way to Health. <ref type="bibr" target="#b31">32</ref></s><s xml:id="_SzZJBps">ansplant Adherence Trial Am J Kidney Dis.</s><s xml:id="_5PQmJ5p">2017;69(3):400-409</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_e2mxCNM">Interventions</head><p xml:id="_vYGfd9r"><s xml:id="_hmcYNyE">Participants were randomly assigned 1:1:1 in blocks of 3 or 6 with no stratification to adherence monitoring with customized reminders (arm 1: reminders group), adherence monitoring with customized reminders plus provider notification (arm 2: reminders-plus-notification group), or wireless pill bottle use alone (arm 3: control group).</s><s xml:id="_up4S9SZ">For each participant receiving reminders (arms 1 and 2), a light on the bottle would illuminate and the cap would chime when the medication was due.</s><s xml:id="_7aNhjxr">Participants could select additional reminders, including texts or telephone calls with recorded messages or e-mails with a weekly adherence summary.</s><s xml:id="_66HeXaS">Each participant could change their intended times of taking medication and/or reminders.</s></p><p xml:id="_DkNYXjs"><s xml:id="_8WXezds">For each participant in the reminders-plus-notification group (arm 2), the percentage of pill bottle2measured adherence was calculated every 2 weeks by Way to Health.</s><s xml:id="_mB7RU6M">If adherence decreased to ,90%, the study coordinator would telephone the participant to ascertain whether there was evidence of pill bottle malfunction.</s><s xml:id="_MfmCpuV">The study coordinator would enter a note into the electronic medical record (Item S1, provided as online supplementary material), copied to the participant's transplant nephrologist and the transplantation coordinator, regarding concerns about suboptimal adherence and a summary of the call.</s></p><p xml:id="_jZJ2yFP"><s xml:id="_59TU8ZB">Participants in the control group (arm 3) received a wireless pill bottle that provided no alerts and only tracked adherence.</s></p><p xml:id="_hZXyfzx"><s xml:id="_5t4PmWH">The wireless bottles resembled a standard pill bottle, provided as a kit with (1) a cap that sent a timestamp when it was removed, and (2) a plug-in gateway that transmitted this information via cellular network to the bottle's manufacturer <ref type="bibr" target="#b29">30</ref> and the Way to Health platform.</s></p><p xml:id="_W9geCwR"><s xml:id="_8yyBYnF">While traveling, the participant could use the bottle or both the bottle and gateway.</s><s xml:id="_fHgXm3c">If a participant traveled outside a cellular network, the pill bottle could store up to 1 month of data and download data when reconnected to the gateway and a cellular signal.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vada8bq">Outcomes</head><p xml:id="_3kWnZGS"><s xml:id="_uEWYNDn">The primary outcome was adherence measured by the pill bottle, calculated for the final 90 days of the intervention period as percentage of days with bottle openings as expected from the intended timing of daily tacrolimus dosing.</s><s xml:id="_FjB8rh3">Adherence was estimated for the first half (2 AM to 2 PM) separately from the second half (2 PM to 2 AM) of the day.</s><s xml:id="_2wzrZzD">The outcome of the final 90 days was selected because adherence is likely to be uniformly high in the immediate weeks after transplantation, when recipients are seen at frequent intervals. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b33">34</ref></s><s xml:id="_SHCWPKe">dherence data collection ended at transplant failure and death.</s><s xml:id="_j3pTKeB">Secondary outcomes included: (1) pill-bottle-measured adherence between 14 days and the end of the study; (2) the coefficient of variation of tacrolimus blood concentrations (calculated within each participant), drawn as a morning trough level approximately 12 hours after the preceding evening dose, measured by center protocol at routine intervals (twice weekly in the first posttransplantation month, weekly in the second posttransplantation month; biweekly from 3 to 6 months <ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref> ); (3) the coefficient of variation of any morning tacrolimus blood concentration, measured for any indication; and (4) the Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS), a validated 5-item self-reported questionnaire specific to immunosuppression, administered at study end. <ref type="bibr" target="#b37">38</ref></s><s xml:id="_rC9gqZb">e performed 3 post hoc analyses.</s><s xml:id="_xtBa8zy">First, we compared pillbottle-measured adherence with censoring of data when participants appeared to permanently discontinue pill bottle use.</s><s xml:id="_Us8Ag5A">Blinded to study arm, 2 investigators (J.T.-C.</s><s xml:id="_YAuYwUy">and S.L.) independently assessed the time of pill bottle discontinuation by visually examining adherence figures and tacrolimus levels for each participant; disagreements were resolved by discussion and adjudication with a third investigator (D.L.).</s><s xml:id="_B4QyqcJ">Second, we compared adherence in the final 6 weeks.</s><s xml:id="_JbdF5z9">Third, we treated days when participants were hospitalized as fully adherent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uPT3Hra">Participant Characteristics</head><p xml:id="_FVKzkCk"><s xml:id="_3A4Ua3V">During enrollment, participants completed the Zimet Multidimensional Scale of Perceived Social Support. <ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b39">40</ref></s><s xml:id="_bbrZM5R">Participants reported age, sex, race, Hispanic ethnicity, education level, and household income.</s><s xml:id="_FjrrpdM">We obtained information about cause of chronic kidney failure, prior dialysis, and comorbid conditions from the medical record.</s></p><p xml:id="_ZaJT7ZN"><s xml:id="_HxXJ8V6">At a routine clinic visit during the first 10 days after transplantation, the pharmacist reviewed each participant's medications, adverse effects, approach to organizing medications, and immunosuppression adherence. <ref type="bibr" target="#b40">41</ref></s><s xml:id="_KtCqMtq">This information was entered into the medical record and used to complete an adherence assessment (Item S2) using a Likert scale.</s><s xml:id="_UaaHrsY">The scale asked the pharmacist to rate agreement with this statement: "I am concerned that this patient will have difficulty with immunosuppression medication adherence."</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_GdVxXK2">Study Operations</head><p xml:id="_yaYyVUA"><s xml:id="_yWqWrPQ">At weeks 5, 9, and 17, each participant was asked to confirm tacrolimus dosing, bottle function, and any hospitalizations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qMzp8zk">Statistical Analyses</head><p xml:id="_CsGAYS6"><s xml:id="_rUC5NtB">Prior literature has not established what difference in immunosuppression adherence would lead to worse clinical outcomes.</s><s xml:id="_Se3pe48">However, a large study of kidney transplant recipients reported that immunosuppression adherence of 81.1% to 95% versus $99.8% (measured by medication possession ratio) was associated with higher risk for transplant loss. <ref type="bibr" target="#b41">42</ref></s><s xml:id="_CxZpcPy">Assuming 80% adherence among controls and using a Bonferroni-adjusted 2-sided type I error rate of 0.025 to adjust for the 2 hypothesis tests, 30 participants per arm provide 80% power to detect an 8% improvement in adherence in arms 2 or 3 compared to arm 1.</s><s xml:id="_vNNvF82">We inflated sample size by 25% to account for dropout, resulting in a total sample size of 120.</s></p><p xml:id="_cw6Q9f3"><s xml:id="_dnxYxmX">We conducted analyses using SAS (version 9.3, 2011; SAS Institute Inc) with 2-sided P , 0.05 as the criterion for statistical significance.</s><s xml:id="_EnC5mBa">Median values are reported with interquartile ranges.</s><s xml:id="_kkemMAE">We compared distributions of demographic variables and tacrolimus levels using the F test (analysis of variance, across all 3 arms) or t test (between 2 groups) for continuous variables and Pearson c 2 test or Fisher exact test for categorical variables.</s><s xml:id="_bPS2k4V">Kruskal-Wallis test was used to compare differences in self-reported tacrolimus adherence.</s></p><p xml:id="_RM4u9U3"><s xml:id="_9W9Eh7J">We estimated daily odds of bottle-measured adherence using generalized estimating equation models that produced robust standard errors by assuming an autoregressive correlation structure for repeated measurement (per patient) while adjusting for study arm as a fixed effect.</s><s xml:id="_ZVstG5A">Differences in predicted proportion of pill bottle opening and 95% confidence intervals (CIs) were derived from bootstrap procedures by resampling patients within arm. <ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b43">44</ref></s><s xml:id="_2jJhCv9">e adjusted for both arm and time (weeks) when evaluating the pharmacist's assessment of adherence.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Qe7Nj3n">RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PysR6aN">Study Participants</head><p xml:id="_esM7EWQ"><s xml:id="_JDYRpYq">Participants were recruited from February 2012 through March 2014.</s><s xml:id="_rx8Q9cU">As shown in Fig <ref type="figure" target="#fig_0">1</ref>, of 376 kidney transplant recipients, 266 were approached about the study and 120 (45%) enrolled.</s><s xml:id="_zgjGcUj">As displayed in Table <ref type="table" target="#tab_0">1</ref>, mean age of participants was 50 6 11 years (standard deviation); 60% were men, 40% were black, and 12% had received a prior transplant.</s><s xml:id="_NKS2xSy">There were no significant differences in demographic or clinical characteristics across arms.</s><s xml:id="_t7jb76V">Table <ref type="table" target="#tab_0">S1</ref> compares participants versus all transplantation kidney transplant recipients undergoing transplantation during the recruitment period.</s></p><p xml:id="_HFwHYjD"><s xml:id="_s2qqha5">Three participants dropped out within the first week: 2 before receiving the intervention and 1 after enrollment due to a subsequent decision by the care team to discharge the patient to an acute-care facility.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_aTGPYPB">Adherence Measured by Pill Bottle</head><p xml:id="_eQHgKfC"><s xml:id="_q6kBYzZ">Figure <ref type="figure" target="#fig_1">2</ref> shows adherence to tacrolimus during the trial.</s><s xml:id="_RNUhAX8">For the primary outcome, the last 90 days of the trial, mean adherence was 78% in the reminders group (arm 1) and 88% in the reminders-plus-notification group (arm 2).</s><s xml:id="_X5hYMuw">Compared to 55% adherence in the control group (arm 3), adherence in the reminders group and the reminders-plus-notification group was significantly higher (by 24% [95% CI, 10%-38%] and 33% [95% CI, 21%-46%], respectively; P , 0.001 for comparisons of each intervention to control).</s><s xml:id="_mrgWpdU">During this period, adherence in the reminders-plusnotification group was marginally higher than in the reminders group (by 10%; 95% CI, 0%-19%; P 5 0.05).</s><s xml:id="_8zKxTwV">Adherence in the reminders and control groups declined during this period (Table <ref type="table" target="#tab_1">S2</ref>).</s></p><p xml:id="_2q2FHma"><s xml:id="_wSqp6Z3">In an analysis of day 14 through end of study, adherence in the reminders group (82%) and reminders-plus-notification group (88%) was higher than the 58% adherence in the control group (by 23% [95% CI, 11%-36%] and 30% [95% CI, 18%-42%], respectively; P , 0.001 for both), but not significantly different between intervention arms (difference in reminders vs reminders-plus-notification.</s><s xml:id="_wS3Qvan">27%; 95% CI, 214% to 1%; P 5 0.1).</s></p><p xml:id="_ym5Xkny"><s xml:id="_ncyVwqc">Results were unchanged in analyses in which we defined a half-day interval as midnight to noon and noon to midnight.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_K8H35E9">Post Hoc Analyses</head><p xml:id="_bk5gymS"><s xml:id="_6PmVr8R">In an analysis during the last 90 days with censoring for suspected discontinued use of the pill bottle, adherence in the reminders group (88%) and reminders-plus-notification group (90%) was higher than the 64% adherence in the control group (by 25% [95% CI, 13%-37%] and 27% [95% CI, 15%-40%], respectively; P , 0.001 for each comparison; Fig <ref type="figure" target="#fig_0">S1</ref>).</s></p><p xml:id="_d9bTYSt"><s xml:id="_GjPkFmU">In the last 6 weeks, adherence in the reminders-plusnotification group (88%) was 15% (95% CI, 2%-27%) higher than in the reminders group (73%; P 5 0.02).</s></p><p xml:id="_CVv6rM6"><s xml:id="_d4KE2GT">Results were unchanged from the primary analysis when we treated days when participants were hospitalized as adherent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qvBBahT">Tacrolimus Whole-Blood Trough Concentrations</head><p xml:id="_h7NkebR"><s xml:id="_yzeNMpr">As shown in Table <ref type="table" target="#tab_1">2</ref>, there were no significant differences across arms in scheduled tacrolimus levels, tacrolimus coefficients of variation, or percent of tacrolimus measurements that were in range according to program standards.</s><s xml:id="_5pMQJ8B">Secondary analysis of all measured tacrolimus levels also showed no differences across arms.</s><s xml:id="_HCw44A4">Am J Kidney Dis.</s><s xml:id="_f39eZ42">2017;69(3):400-409</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_esKx9fE">Self-rated Adherence</head><p xml:id="_xwz58f5"><s xml:id="_bg7vv8R">At the end of the trial, using the BAASIS adherence questionnaire, 22% of participants affirmed some episodes of nonadherence; this percentage did not differ across arms (P 5 0.8; Table <ref type="table" target="#tab_2">3</ref>).</s><s xml:id="_QGxGGWm">On a scale of 0% to 100%, nearly all participants rated their adherence close to 100%.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XqAD55h">Clinical Outcomes</head><p xml:id="_uBERtSu"><s xml:id="_wC5VmGC">No adverse events (including serious adverse events) were considered unexpected and related to trial participation.</s><s xml:id="_wNTKjjG">During the 180-day intervention period, 1 participant had transplant failure and 1 died, at which point data were censored.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_tCDxsGD">Qualitative Data</head><p xml:id="_ZVvwb2E"><s xml:id="_eU75EgF">Many participants expressed appreciation for the reminders provided by the pill bottle.</s><s xml:id="_FpmbWgm">Transplant recipients at our institution are provided with a pill box to organize medications, but few reported difficulty integrating the wireless pill bottle into their pill-taking routine.</s></p><p xml:id="_GhYRTJ2"><s xml:id="_54YXmDX">As shown in Table <ref type="table" target="#tab_2">S3</ref>, there were 61 provider notifications for participants in the reminders-plusnotification group (arm 2).</s><s xml:id="_TYM2UQU">The study coordinator assessed that many of the 2-week alerts of adherence ,90% for arm 2 participants were due to pill bottle and/or user error.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_urRUCDf">Pharmacist Assessment of Adherence</head><p xml:id="_egHWTtG"><s xml:id="_7K5Cft9">Adjusting for study arm and time (week), poor adherence was predicted by the pharmacist's agreement with a statement of concern about the patient's adherence problems early after transplantation ("Strongly agree" response: odds ratio, 0.22; 95% CI, 0.06-0.72;</s><s xml:id="_Z3wMyfU">P , 0.05; C statistic, 0.726; Table <ref type="table">S4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qb257KR">DISCUSSION</head><p xml:id="_asUMyYp"><s xml:id="_NhUmNrK">This pilot trial demonstrated the feasibility of integrating wireless pill bottles into the early posttransplantation period and using continuously collected adherence data for real-time interventions.</s><s xml:id="_E6v9CR6">Compared with participants in the control group, pill-bottle2measured adherence was significantly higher among participants randomly assigned to the reminders and reminders-plus-notification groups.</s><s xml:id="_9mncnfG">However, we did not detect differences in the secondary outcome of tacrolimus level coefficients of variation between arms.</s><s xml:id="_BstWHVW">These results demonstrate the need for larger multicenter studies with sufficient power to quantify the degree to which adherence interventions may translate into differences in clinical outcomes.</s></p><p xml:id="_X8FvUM3"><s xml:id="_9EGWZep">We found that the combination of automated reminders and provider notification led to consistently high adherence (88% vs 55% for control) during the first 6 months after transplantation, when rejection risk is most elevated.</s><s xml:id="_UeSENq9">An observational study that relied on medical possession ratio to assess adherence would suggest that the effect size in our trial could improve transplant survival, although our trial was not powered to detect effects on transplant survival. <ref type="bibr" target="#b41">42</ref></s><s xml:id="_tDBCcGC">ill-bottle2measured adherence in the reminders and control groups gradually declined during the final 90 days of the trial.</s><s xml:id="_TRTpUzy">Worsening adherence over time in the groups without provider notification is consistent with studies in transplant recipients and other patient groups. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b45">46</ref></s><s xml:id="_5zyzGt6">Posttransplantation, declining Am J Kidney Dis.</s><s xml:id="_feeVaUu">2017;69(3):400-409</s></p><p xml:id="_g7PySw8"><s xml:id="_wSWkvr8">adherence over time may be related to less frequent clinical visits, with fewer reminders about the importance of immunosuppression.</s><s xml:id="_8wce9zY">Notably, reminders with provider notification only appeared to improve adherence versus reminders alone in a post hoc comparison of the final 6 weeks.</s><s xml:id="_R42ffUY">A potential explanation is that reminders lose efficacy over time (alarm fatigue), whereas the influence of provider notification was more enduring.</s><s xml:id="_hPgM3YR">Given that provider notification alerts took place infrequently, the main mechanism of this intervention may have been social pressure; ie, participants took their tacrolimus (or used wireless pill bottles) more consistently to preclude having their nonadherence detected by providers.</s><s xml:id="_nvtqv64">However, better adherence in the 2 intervention arms was not reflected in differences in tacrolimus troughs.</s><s xml:id="_BRDkGhT">One potential explanation was that actual tacrolimus adherence was similar across arms and that participants in the control group were simply less adherent using the wireless pill bottles.</s><s xml:id="_7j3jYqH">However, an exploratory analysis with censoring when patients appeared to permanently stop using the wireless pill bottles also demonstrated significantly better adherence in the 2 intervention arms versus the control group.</s><s xml:id="_Hbe8dz2">A second possibility is that tacrolimus level coefficients of variation (or standard deviations) do not accurately capture adherence.</s><s xml:id="_aT4shwU">Some prior studies have demonstrated an association between tacrolimus level coefficient of variation and clinical outcomes such as rejection, although these assessments have important limitations. <ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b46">47</ref></s><s xml:id="_JnYb7Dw">For instance, the patient must not take the tacrolimus pill until after blood is drawn to get an accurate trough.</s><s xml:id="_5tuEqXN">Some of the highest tacrolimus levels (and variation) in clinical practice probably result from patients erroneously taking their tacrolimus before phlebotomy.</s><s xml:id="_qnTKQwm">Therefore, it is possible that high tacrolimus coefficients of variation succeed in identifying a general limitation in the ability to follow complex instructions, rather than identifying individuals with the greatest problems with daily immunosuppression adherence.</s></p><p xml:id="_Wnkd7Sj"><s xml:id="_MqcFX77">These results should motivate larger adherence studies in transplantation that pair wireless pill bottles with theory-driven interventions and sufficient statistical power to quantify whether these types of interventions improve clinical and/or immunologic outcomes. <ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref></s><s xml:id="_CVdh3Hh">9]<ref type="bibr" target="#b49">[50]</ref> The cost of these devices is likely to decrease. <ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b50">51,</ref><ref type="bibr" target="#b51">52</ref></s><s xml:id="_3gCq3Ez">In the transplantation setting, reminders and provider notification have the advantages of scalability and the ability to customize the intervention to the participant.</s><s xml:id="_8S4yB8M">Because kidney transplantation extends survival and provides better quality of life for lower cost compared to maintenance dialysis, investments in medication adherence after transplantation could plausibly be cost-effective. <ref type="bibr" target="#b52">53,</ref><ref type="bibr" target="#b53">54</ref></s><s xml:id="_Exz4pm5">ne study of Medicare claims for immunosuppression in 15,525 kidney transplant recipients found that persistently low adherence was associated with $12,840 higher 3-year medical costs per recipient versus recipients with high adherence. <ref type="bibr" target="#b41">42</ref></s><s xml:id="_7t2kFJB">Recent studies also suggest that a variety of alternative behavior change strategies such as behavioral contracting (in a kidney transplant recipient population), financial incentives (among general internal medicine patients), and reciprocal peer support (among African American veterans with diabetes) could be useful in promoting medication adherence in the organ transplantation setting. <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b54">55,</ref><ref type="bibr" target="#b55">56</ref></s><s xml:id="_tThG5GX">In addition to measuring clinical outcomes, investigators designing future transplantation adherence studies should consider innovative measures of immunologic reactivity, including peripheral-blood whole-genome gene expression profiles, donor-specific antibody, and urine messenger RNA and metabolite profiles. <ref type="bibr" target="#b56">57,</ref><ref type="bibr" target="#b57">58</ref></s><s xml:id="_WbG6nRq">e acknowledge our study's limitations.</s><s xml:id="_dwsQXzF">Outcomes were limited to adherence measurements, all of which have shortcomings.</s><s xml:id="_g4Nw6PS">The pill bottles measure only openings, not actual pill ingestion.</s><s xml:id="_WvSwybM">The bottles cannot distinguish between opening the cap for resupplying the bottle with tacrolimus versus opening for taking tacrolimus.</s><s xml:id="_sMNSYuP">The study did not limit enrollment to patients with a high probability of having adherence challenges.</s><s xml:id="_mggWwTw">Although the principal investigator, pharmacist, and statistical analysts were blinded to study arm, the study coordinators were not.</s><s xml:id="_g7TeN4g">Another limitation is that compared with the reminders group and control group, study coordinators had more contact with participants in the reminders-plusnotification arm, prompted by low-adherence events.</s><s xml:id="_ZMvvxk2">This increased contact, rather than provider notification, might have explained the higher adherence in that arm.</s><s xml:id="_uYxFjGN">Additionally, this study focused on only tacrolimus adherence, although kidney transplant recipients often take 10 or more medications. <ref type="bibr" target="#b58">59</ref></s><s xml:id="_w5y4zQY">We chose to focus on tacrolimus adherence because tacrolimus is the most effective maintenance immunosuppressant in kidney transplantation; better adherence could plausibly improve transplantation outcomes.</s></p><p xml:id="_EvNChgg"><s xml:id="_g2shtKV">In summary, this pilot trial demonstrated the feasibility of implementing wireless pill bottles into the care of kidney transplant recipients.</s><s xml:id="_Mqr8y8S">The strategies of adherence monitoring with customized reminders and customized reminders with provider notification led to improved tacrolimus adherence versus control as estimated by the wireless pill bottle, although tacrolimus levels were similar across trial arms.</s><s xml:id="_pcEDMJH">Transplantation pharmacists were able to successfully identify participants at high risk for poor medication adherence.</s><s xml:id="_m8YfGet">These results should inform the design and conduct of larger multicenter trials with clinical end points.</s><s xml:id="_b9WxZRR">Contributions: Research idea and study design: PPR, RDB, HIF, JZ, JT-C, KV; data acquisition: PPR, AM, SL, JT-C, DL; data analysis/interpretation: all authors; statistical analysis: AT, JZ, LY, WW.</s><s xml:id="_a47xpkT">Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.</s><s xml:id="_QNCyjyj">PPR takes responsibility that this study has been reported honestly, accurately, and transparently; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned and registered have been explained.</s></p><p xml:id="_EmqFBf3"><s xml:id="_7DJZSjs">Peer Review: Evaluated by 2 external peer reviewers, a Statistical Editor, a Co-Editor, and Editor-in-Chief Levey.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_RRuWJ8m"><s xml:id="_pJumgJ3">Figure 1.</s><s xml:id="_NSP7QtJ">CONSORT diagram.</s></p></div></figDesc><graphic coords="4,103.41,67.69,387.36,253.42" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_TZ6YCN3"><s xml:id="_Zwj9sx2">Figure 2. Weekly proportion of participants with pill bottle opening.</s></p></div></figDesc><graphic coords="6,69.28,67.69,455.52,295.77" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>and</head><figDesc><div><p xml:id="_BegRYBD"><s xml:id="_HZF4qU3">Dohme for other studies of medication adherence, which provided salary support to Drs Reese and Volpp.</s><s xml:id="_URRXUss">Dr Volpp is a principal at the behavioral economics consulting firm VAL Health and has received consulting income and research support from CVS Health and research support from Humana, Weight Watchers, the Hawaii Medical Services Association, and the Vitality Institute (not related to Vitality Inc, the manufacturer of the GlowCaps pill bottle).</s><s xml:id="_KMkUbsZ">Dr Troxel has received consulting income from VAL Health and research support from the Vitality Institute, the Hawaii Medical Services Association, and Weight Watchers.</s><s xml:id="_A7ygW2N">After the trial interventions were completed, the University of Pennsylvania received research support from Veloxis Pharma, which provided salary support for Dr Trofe-Clark; she also received honorarium from Veloxis Pharma after this study was conducted.</s><s xml:id="_jzcDtn6">The other authors declare that they have no other relevant financial interests.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_j3fuKvX"><s xml:id="_fjKGCHe">Participant Characteristics</s></p></div></figDesc><table><row><cell>Mean age, y</cell><cell>50 6 11</cell><cell>50 6 12</cell><cell>50 6 11</cell><cell>49 6 11</cell><cell>0.09 (A); 0.9</cell></row><row><cell>Age category</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.53 (c); 0.9</cell></row><row><cell>,40 y</cell><cell>18 (15)</cell><cell>6 (15)</cell><cell>5 (13)</cell><cell>7 (18)</cell><cell></cell></row><row><cell>40-60 y</cell><cell>83 (69)</cell><cell>27 (68)</cell><cell>29 (73)</cell><cell>27 (68)</cell><cell></cell></row><row><cell>.60 y</cell><cell>19 (16)</cell><cell>7 (18)</cell><cell>6 (15)</cell><cell>6 (15)</cell><cell></cell></row><row><cell>Sex</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.21 (c); 0.9</cell></row><row><cell>Female</cell><cell>48 (40)</cell><cell>15 (38)</cell><cell>17 (43)</cell><cell>16 (40)</cell><cell></cell></row><row><cell>Male</cell><cell>72 (60)</cell><cell>25 (63)</cell><cell>23 (58)</cell><cell>24 (60)</cell><cell></cell></row><row><cell>Race</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>2.11 (c); 0.7</cell></row><row><cell>White</cell><cell>65 (54)</cell><cell>18 (45)</cell><cell>24 (60)</cell><cell>23 (58)</cell><cell></cell></row><row><cell>Black</cell><cell>48 (40)</cell><cell>19 (48)</cell><cell>14 (35)</cell><cell>15 (38)</cell><cell></cell></row><row><cell>Other</cell><cell>7 (6)</cell><cell>3 (8)</cell><cell>2 (5)</cell><cell>2 (5)</cell><cell></cell></row><row><cell>Hispanic ethnicity</cell><cell>4 (3)</cell><cell>1 (3)</cell><cell>2 (5)</cell><cell>1 (3)</cell><cell>0.52 (c); 0.8</cell></row><row><cell>Income category</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>5.12 (c); 0.5</cell></row><row><cell>#$20,000</cell><cell>19 (17)</cell><cell>6 (15)</cell><cell>8 (24)</cell><cell>5 (13)</cell><cell></cell></row><row><cell>$20,001-$60,000</cell><cell>33 (30)</cell><cell>16 (41)</cell><cell>7 (21)</cell><cell>10 (26)</cell><cell></cell></row><row><cell>$60,001-$100,000</cell><cell>31 (28)</cell><cell>9 (23)</cell><cell>10 (29)</cell><cell>12 (32)</cell><cell></cell></row><row><cell>$$100,001</cell><cell>28 (25)</cell><cell>8 (21)</cell><cell>9 (26)</cell><cell>11 (29)</cell><cell></cell></row><row><cell>Missing</cell><cell>9</cell><cell>1</cell><cell>6</cell><cell>2</cell><cell></cell></row><row><cell>Education level</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>2.4 (c); 0.7</cell></row><row><cell>#12 y</cell><cell>34 (28)</cell><cell>13 (33)</cell><cell>12 (30)</cell><cell>9 (23)</cell><cell></cell></row><row><cell>13-16 y</cell><cell>59 (49)</cell><cell>19 (48)</cell><cell>17 (43)</cell><cell>23 (58)</cell><cell></cell></row><row><cell>$17 y</cell><cell>27 (23)</cell><cell>8 (20)</cell><cell>11 (28)</cell><cell>8 (20)</cell><cell></cell></row><row><cell>Cause of CKF</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(F); 0.5</cell></row><row><cell>Other</cell><cell>34 (28)</cell><cell>10 (25)</cell><cell>13 (33)</cell><cell>11 (28)</cell><cell></cell></row><row><cell>Diabetes</cell><cell>29 (24)</cell><cell>13 (33)</cell><cell>8 (20)</cell><cell>8 (20)</cell><cell></cell></row><row><cell>FSGS, IgA, other GN</cell><cell>31 (26)</cell><cell>12 (30)</cell><cell>8 (20)</cell><cell>11 (28)</cell><cell></cell></row><row><cell>Hypertension</cell><cell>13 (11)</cell><cell>3 (8)</cell><cell>7 (18)</cell><cell>3 (8)</cell><cell></cell></row><row><cell>PCKD</cell><cell>13 (11)</cell><cell>2 (5)</cell><cell>4 (10)</cell><cell>7 (18)</cell><cell></cell></row><row><cell>Dialysis at time of Tx</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>2.97 (c); 0.6</cell></row><row><cell>Hemodialysis</cell><cell>63 (53)</cell><cell>23 (58)</cell><cell>22 (55)</cell><cell>18 (45)</cell><cell></cell></row><row><cell>Peritoneal dialysis</cell><cell>26 (22)</cell><cell>8 (20)</cell><cell>10 (25)</cell><cell>8 (20)</cell><cell></cell></row><row><cell>No dialysis</cell><cell>31 (26)</cell><cell>9 (23)</cell><cell>8 (20)</cell><cell>14 (35)</cell><cell></cell></row><row><cell>Prior Tx</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.16 (c); 0.9</cell></row><row><cell>No</cell><cell>106 (88)</cell><cell>35 (88)</cell><cell>36 (90)</cell><cell>35 (88)</cell><cell></cell></row><row><cell>Yes</cell><cell>14 (12)</cell><cell>5 (13)</cell><cell>4 (10)</cell><cell>5 (13)</cell><cell></cell></row><row><cell>Kidney donor type</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.49 (c); 0.8</cell></row><row><cell>Deceased</cell><cell>74 (62)</cell><cell>25 (63)</cell><cell>26 (65)</cell><cell>23 (58)</cell><cell></cell></row><row><cell>Living</cell><cell>46 (38)</cell><cell>15 (38)</cell><cell>14 (35)</cell><cell>17 (43)</cell><cell></cell></row><row><cell>Total MSPSS score</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>2.4 (K); 0.3</cell></row><row><cell>Median</cell><cell>6.8 [6.1-7.0]</cell><cell>6.8 [5.8-7.0]</cell><cell>6.6 [6.1-7.0]</cell><cell>7.0 [6.3-7.0]</cell><cell></cell></row><row><cell>No. of missing</cell><cell>11</cell><cell>2</cell><cell>4</cell><cell>5</cell><cell></cell></row><row><cell cols="6">Note: Unless otherwise indicated, values for categorical variables are given as number (percentage); values for continuous vari-</cell></row><row><cell cols="3">ables, as mean 6 standard deviation or median [interquartile range].</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="6">Abbreviations: A, analysis of variance F test; c, Pearson c 2 test; CKF, chronic kidney failure; F, Fisher exact test; FSGS, focal</cell></row><row><cell cols="6">segmental glomerulosclerosis; GN, glomerulonephritis; IgA, immunoglobulin A; K, Kruskal-Wallis test; MSPSS, Zimet Multidimensional</cell></row><row><cell cols="4">Scale of Perceived Social Support; PCKD, polycystic kidney disease; Tx, transplant(ation).</cell><cell></cell><cell></cell></row></table><note xml:id="_34rMZNw"><p><s xml:id="_pT6zuXB">Variables Total (N 5 120) Reminders (n 5 40) Reminders 1 Notification (n 5 40) Control (n 5 40) Test Statistic; P</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s xml:id="_2vAWqPU">Tacrolimus Serum Concentrations Between Study ArmsNote: Unless otherwise indicated, values are given as mean 6 standard deviation or median [interquartile range].</s><s xml:id="_s6Y6a4X">Tac measurements are based on routine measurements defined by clinical protocols for all patients in the transplant program.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell>Reminders 1</cell><cell></cell><cell></cell></row><row><cell>Variables</cell><cell>Total (N 5 117)</cell><cell>Reminders (n 5 40)</cell><cell>Notification (n 5 39)</cell><cell>Control (n 5 38)</cell><cell>Test Statistic; P</cell></row><row><cell>Tac level</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Mean</cell><cell>9.17 6 1.39</cell><cell>9.25 6 1.38</cell><cell>9.17 6 1.41</cell><cell>9.08 6 1.42</cell><cell>0.14 (A); 0.9</cell></row><row><cell>Median</cell><cell>9.04 [8.33-9.77]</cell><cell>9.11 [8.34-9.80]</cell><cell>9.20 [8.04-10.0]</cell><cell>8.93 [8.44-9.51]</cell><cell>0.63 (K); 0.7</cell></row><row><cell>No. of missing</cell><cell>1</cell><cell>0</cell><cell>0</cell><cell>1</cell><cell></cell></row><row><cell>CVs for Tac level</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Mean</cell><cell>0.26 6 0.13</cell><cell>0.25 6 0.14</cell><cell>0.26 6 0.11</cell><cell>0.26 6 0.13</cell><cell>0.05 (A); 0.9</cell></row><row><cell>Median</cell><cell>0.23 [0.18-0.31]</cell><cell>0.22 [0.17-0.29]</cell><cell>0.23 [0.19-0.32]</cell><cell>0.24 [0.18-0.31]</cell><cell>1.00 (K); 0.6</cell></row><row><cell>No. of missing</cell><cell>1</cell><cell>0</cell><cell>0</cell><cell>1</cell><cell></cell></row><row><cell>Percentage of Tac measurements</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>in range a</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Mean</cell><cell>0.47 6 0.20</cell><cell>0.44 6 0.20</cell><cell>0.46 6 0.20</cell><cell>0.53 6 0.19</cell><cell>2.5 (A); 0.09</cell></row><row><cell>Median</cell><cell>0.43 [0.33-0.60]</cell><cell>0.43 [0.29-0.57]</cell><cell>0.43 [0.33-0.60]</cell><cell>0.57 [0.43-0.67]</cell><cell>5.12 (K); 0.08</cell></row><row><cell>No. of missing</cell><cell>1</cell><cell>0</cell><cell>0</cell><cell>1</cell><cell></cell></row><row><cell>Tac level in final 3 mo</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Mean</cell><cell>8.39 6 2.06</cell><cell>8.70 6 2.70</cell><cell>8.08 6 1.56</cell><cell>8.38 6 1.67</cell><cell>0.86 (A); 0.4</cell></row><row><cell>Median</cell><cell>8.07 [7.15-9.00]</cell><cell>8.17 [7.27-9.00]</cell><cell>8.03 [6.80-9.10]</cell><cell>7.90 [7.28-8.97]</cell><cell>0.43 (K); 0.8</cell></row><row><cell>No. of missing</cell><cell>4</cell><cell>0</cell><cell>2</cell><cell>2</cell><cell></cell></row><row><cell>CVs for Tac level in final 3 mo</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Mean</cell><cell>0.23 6 0.16</cell><cell>0.23 6 0.18</cell><cell>0.21 6 0.15</cell><cell>0.24 6 0.15</cell><cell>0.3 (A); 0.7</cell></row><row><cell>Median</cell><cell>0.19 [0.13-0.26]</cell><cell>0.19 [0.11-0.25]</cell><cell>0.18 [0.14-0.24]</cell><cell>0.22 [0.13-0.26]</cell><cell>1.57 (K); 0.5</cell></row><row><cell>No. of missing</cell><cell>12</cell><cell>3</cell><cell>5</cell><cell>4</cell><cell></cell></row><row><cell>Percentage of Tac measurements</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>in range in final 3 mo</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Mean</cell><cell>0.38 6 0.30</cell><cell>0.35 6 0.32</cell><cell>0.37 6 0.26</cell><cell>0.42 6 0.30</cell><cell>0.55 (A); 0.6</cell></row><row><cell>Median</cell><cell>0.33 [0.00-0.67]</cell><cell>0.33 [0.00-0.58]</cell><cell>0.33 [0.33-0.67]</cell><cell>0.33 [0.33-0.67]</cell><cell>0.18 (K); 0.6</cell></row><row><cell>No. of missing</cell><cell>4</cell><cell>0</cell><cell>2</cell><cell>2</cell><cell></cell></row><row><cell cols="6">Abbreviations: A, analysis of variance F test; CV, coefficient of variation; K, Kruskal-Wallis test; Tac, tacrolimus (in ug/L).</cell></row></table><note xml:id="_V44Y5ar"><p>a</p><p><s xml:id="_Rj3zU9k">As defined by study standards.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_kgCMkFc"><s xml:id="_EUZzwE9">Self-reported Adherence Using BAASIS Note: Unless otherwise indicated, values are given as number (percentage) or median [interquartile range].</s><s xml:id="_FV9s9HF">Abbreviations: BAASIS, Basel Assessment of Adherence to Immunosuppressive Medications Scale; c, Pearson c 2 test; K, Kruskal-</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell>Reminders 1</cell><cell></cell><cell></cell></row><row><cell>Variables</cell><cell>Total (N 5 117)</cell><cell>Reminders (n 5 40)</cell><cell>Notification (n 5 39)</cell><cell>Control (n 5 38)</cell><cell>Test Statistic; P</cell></row><row><cell>Adherent</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.58 (c); 0.8</cell></row><row><cell>No</cell><cell>26 (22)</cell><cell>9 (23)</cell><cell>10 (26)</cell><cell>7 (18)</cell><cell></cell></row><row><cell>Yes</cell><cell>91 (78)</cell><cell>31 (78)</cell><cell>29 (74)</cell><cell>31 (82)</cell><cell></cell></row><row><cell>What percentage do you feel you</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>2.18 (K); 0.3</cell></row><row><cell>took your tacrolimus on time?</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Median</cell><cell>100 [95-100]</cell><cell>100 [95-100]</cell><cell>100 [95-100]</cell><cell>99 [95-100]</cell><cell></cell></row><row><cell>No. of missing</cell><cell>12</cell><cell>4</cell><cell>4</cell><cell>4</cell><cell></cell></row><row><cell>Wallis test.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_249kcvJ"><s xml:id="_GyndBfC">Am J Kidney Dis.</s><s xml:id="_UwmTUQs">2017;69(3):400-409</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_DfMDDaZ"><s xml:id="_vZj7r8h">Am J Kidney Dis.</s><s xml:id="_eZBf2Mj">2017;69(3):400-409</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_QQpuAuY">ACKNOWLEDGEMENTS</head><p xml:id="_dw2EkaS"><s xml:id="_9e78uX8">The study team thanks <rs type="person">Lisa Wesby</rs> for advice related to development and customization of the Way to Health Platform and <rs type="person">Daniel R. Stevens, PharmD, BCPS</rs>, and <rs type="person">Tracy Sparkes, PharmD, BCPS</rs>, for work making adherence assessments among study participants.</s></p><p xml:id="_jnfRzxh"><s xml:id="_Natjtrh">Preliminary results of this study were presented at the American Transplant Congress in May 2-6, 2015 in Philadelphia, PA.</s></p><p xml:id="_h2vFZ6e"><s xml:id="_WC8wBNc">Support: Funding for this study was provided by the <rs type="funder">Leonard Davis Institute (LDI)</rs> at the <rs type="institution">University of Pennsylvania</rs> and additional support was provided by the <rs type="funder">LDI's Center for Health Incentives and Behavioral Economics</rs>.</s><s xml:id="_8kGMfBy">The investigators had complete control over the recruitment procedures, data collection, data analysis, presentation, and publication.</s></p><p xml:id="_xZpzcGe"><s xml:id="_rrTPy7H">Financial Disclosure: The <rs type="institution">University of Pennsylvania</rs> has received research support from <rs type="funder">CVS Caremark</rs> and <rs type="funder">Merck</rs>, <rs type="funder">Sharpe</rs>,</s></p></div>
			</div>
			<listOrg type="funding">
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_upm7vjW">SUPPLEMENTARY MATERIAL</head><p xml:id="_p4vKDDR"><s xml:id="_QhzBFDu">Table <ref type="table">S1</ref>: Characteristics of participants vs. all those patients who received a kidney transplant during recruitment period.</s></p><p xml:id="_AvKUsKn"><s xml:id="_78GF8Y4">Table <ref type="table">S2</ref>: Analysis of bottle-measured adherence trends over time during trial.</s></p><p xml:id="_aCmZfkB"><s xml:id="_QXau6UT">Table <ref type="table">S3</ref>: Provider notifications (reminders 1 notification only).</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_cQ64DQj">Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Dew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Dimartini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vito</forename><surname>De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dabbs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_StHyGhS">Transplantation</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="858" to="873" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83:858-873.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_JqhQ7Fb">Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Butler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Roderick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mullee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Mason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Peveler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VWySkXe">Transplantation</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="769" to="776" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation. 2004;77:769-776.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_BgNMuWs">Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence</title>
		<author>
			<persName><forename type="first">J</forename><surname>Sellares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>De Freitas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mengel</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-6143.2011.03840.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_47Y7uQK">Am J Transplant</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="388" to="399" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sellares J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12:388-399.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_dhZGUZf">Predictive patterns of early medication adherence in renal transplantation</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Nevins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">N</forename><surname>Robiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Thomas</surname></persName>
		</author>
		<idno type="DOI">10.1097/tp.0000000000000148</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_daTNjCG">Transplantation</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="878" to="884" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nevins TE, Robiner WN, Thomas W. Predictive patterns of early medication adherence in renal transplantation. Trans- plantation. 2014;98:878-884.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_wSnADmn">Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Prendergast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Gaston</surname></persName>
		</author>
		<idno type="DOI">10.2215/cjn.07241009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yv3RmKk">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1305" to="1311" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Prendergast MB, Gaston RS. Optimizing medication adher- ence: an ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol. 2010;5:1305-1311.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_bX795gp">Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the integrative model of behavioral prediction: a cross-sectional study</title>
		<author>
			<persName><forename type="first">G</forename><surname>Schmid-Mohler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Thut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Wuthrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Denhaerynck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Geest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gyTAVSn">Clin Transplant</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="213" to="222" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schmid-Mohler G, Thut MP, Wuthrich RP, Denhaerynck K, De Geest S. Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the integrative model of behavioral prediction: a cross-sectional study. Clin Transplant. 2010;24:213-222.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_vnpcHBt">Nonadherence consensus conference summary report</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Fine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Geest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xpeVjjT">Am J Transplant</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="35" to="41" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant. 2009;9: 35-41.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_kBTcVVP">Discrepancies between beliefs and behavior: a prospective study into immunosuppressive medication adherence after kidney transplantation</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Massey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tielen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laging</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uFhB2V8">Transplantation</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="375" to="380" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Massey EK, Tielen M, Laging M, et al. Discrepancies be- tween beliefs and behavior: a prospective study into immuno- suppressive medication adherence after kidney transplantation. Transplantation. 2015;99:375-380.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_D9c7Mhz">Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Bravin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Garcia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_as9FAPT">Int Urol Nephrol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1899" to="1905" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Garcia MF, Bravin AM, Garcia PD, et al. Behavioral mea- sures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. Int Urol Nephrol. 2015;47:1899-1905.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_gWTRwxq">The TAKE-IT study: aims, design, and methods</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Furth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Take-It Study</forename><surname>Group</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2369-15-139</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hSDDE3y">BMC Nephrol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">139</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Foster BJ, Pai A, Zhao H, Furth S, TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrol. 2014;15:139.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_4p2jznD">Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Low</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Manias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Crawford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qrnPwDx">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="752" to="761" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Low JK, Williams A, Manias E, Crawford K. Interventions to improve medication adherence in adult kidney transplant re- cipients: a systematic review. Nephrol Dial Transplant. 2015;30: 752-761.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_fNxVWem">Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Chisholm-Burns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Spivey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Graff Zivin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sredzinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Tolley</surname></persName>
		</author>
		<idno type="DOI">10.1111/ajt.12341</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XRQruJX">Am J Transplant</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="2364" to="2373" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chisholm-Burns MA, Spivey CA, Graff Zivin J, Lee JK, Sredzinski E, Tolley EA. Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. Am J Transplant. 2013;13:2364-2373.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_VUXCEYZ">Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Joost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Dorje</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schwitulla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">U</forename><surname>Eckardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hugo</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndt/gfu207</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XzHSTcd">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1597" to="1607" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Joost R, Dorje F, Schwitulla J, Eckardt KU, Hugo C. Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrol Dial Transplant. 2014;29:1597-1607.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_CmDx4Uj">Asymmetric paternalism to improve health behaviors</title>
		<author>
			<persName><forename type="first">G</forename><surname>Loewenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9S43TSZ">JAMA</title>
		<imprint>
			<biblScope unit="volume">298</biblScope>
			<biblScope unit="page" from="2415" to="2417" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298:2415- 2417.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main" xml:id="_sR2uBmN">Introduction to Health Behavior Theory</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hayden</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
			<publisher>Jones and Bartlett</publisher>
			<pubPlace>Sudbury, MA</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Hayden J. Introduction to Health Behavior Theory. Sud- bury, MA: Jones and Bartlett; 2009.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_b9KSzgf">Automated hovering in health care-watching over the 5000 hours</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmp1203869</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3qP8kUa">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="page" from="1" to="3" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Asch DA, Muller RW, Volpp KG. Automated hovering in health care-watching over the 5000 hours. N Engl J Med. 2012;367:1-3.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<author>
			<persName><forename type="first">R</forename><surname>Thaler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sunstein</surname></persName>
		</author>
		<title level="m" xml:id="_qEgdj5U">Nudge: Improving Decisions About Health, Wealth and Happiness</title>
		<meeting><address><addrLine>New Haven, CT</addrLine></address></meeting>
		<imprint>
			<publisher>Yale University Press</publisher>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Thaler R, Sunstein C. Nudge: Improving Decisions About Health, Wealth and Happiness. New Haven, CT: Yale University Press; 2008.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_bBfqJqk">Osteoporosis medication adherence: physician perceptions vs. patients&apos; utilization</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Curtis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Wade</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_V7Xttcw">Bone</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Curtis JR, Cai Q, Wade SW, et al. Osteoporosis medication adherence: physician perceptions vs. patients&apos; utilization. Bone. 2013;55:1-6.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_hs5cN8b">Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss</title>
		<author>
			<persName><forename type="first">J</forename><surname>Meddings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Kerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heisler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Hofer</surname></persName>
		</author>
		<idno type="DOI">10.1186/1472-6963-12-270</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EKWxe5Z">BMC Health Serv Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">270</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Meddings J, Kerr EA, Heisler M, Hofer TP. Physician as- sessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss. BMC Health Serv Res. 2012;12:270.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_rSzM2nJ">How well do clinicians estimate patients&apos; adherence to combination antiretroviral therapy?</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Hays</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1525-1497.2002.09004.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TpYJ5zS">J Gen Intern Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Miller LG, Liu H, Hays RD, et al. How well do clinicians estimate patients&apos; adherence to combination antiretroviral therapy? J Gen Intern Med. 2002;17:1-11.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_2mXAYsc">Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Mukherjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ivers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Leandre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Farmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Behforouz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_p8HKX8F">J Acq Immune Defic Syndr</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">suppl 1</biblScope>
			<biblScope unit="page" from="123" to="S126" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mukherjee JS, Ivers L, Leandre F, Farmer P, Behforouz H. Antiretroviral therapy in resource-poor settings. Decreasing bar- riers to access and promoting adherence. J Acq Immune Defic Syndr. 2006;43(suppl 1):S123-S126.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_fub5yJw">Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Franke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kaigamba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Socci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Vtvs7zN">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="1319" to="1326" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Franke MF, Kaigamba F, Socci AR, et al. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda. Clin Infect Dis. 2013;56:1319-1326.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_AuAg6U7">Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Koenig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Leandre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Farmer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Hmekk36">AIDS</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">suppl 3</biblScope>
			<biblScope unit="page" from="21" to="S25" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Koenig SP, Leandre F, Farmer PE. Scaling-up HIV treat- ment programmes in resource-limited settings: the rural Haiti experience. AIDS. 2004;18(suppl 3):S21-S25.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_mb2GnDP">Living with a kidney transplant: a qualitative investigation of quality of life</title>
		<author>
			<persName><forename type="first">A</forename><surname>Orr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Willis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Britton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Orr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pRtEs5e">J Health Psychol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="653" to="662" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Orr A, Willis S, Holmes M, Britton P, Orr D. Living with a kidney transplant: a qualitative investigation of quality of life. J Health Psychol. 2007;12:653-662.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_Xq4Dwkv">The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Howell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Webster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Craig</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndt/gfq376</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_frXujMD">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="344" to="354" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tong A, Howell M, Wong G, Webster AC, Howard K, Craig JC. The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. Nephrol Dial Transplant. 2011;26:344-354.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_nVzhqrc">Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru</title>
		<author>
			<persName><forename type="first">C</forename><surname>Mitnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bayona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Palacios</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa022928</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FPP5gW2">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="page" from="119" to="128" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med. 2003;348:119-128.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_yFg8tuq">Monitoring therapy compliance of tuberculosis patients by using video-enabled electronic devices</title>
		<author>
			<persName><forename type="first">A</forename><surname>Story</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Garfein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hayward</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bReXYpq">Emerg Infect Dis</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="538" to="540" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Story A, Garfein RS, Hayward A, et al. Monitoring therapy compliance of tuberculosis patients by using video-enabled elec- tronic devices. Emerg Infect Dis. 2016;22:538-540.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_bshX4kw">Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><surname>Thiam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Lefevre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hane</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.297.4.380</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6TFsp7t">JAMA</title>
		<imprint>
			<biblScope unit="volume">297</biblScope>
			<biblScope unit="page" from="380" to="386" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Thiam S, LeFevre AM, Hane F, et al. Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. JAMA. 2007;297:380-386.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_PgYEduf">Physician alerts to increase antidepressant adherence: fax or fiction?</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Z</forename><surname>Bambauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinte.166.5.498</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rrAtVdb">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="page" from="498" to="504" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bambauer KZ, Adams AS, Zhang F, et al. Physician alerts to increase antidepressant adherence: fax or fiction? Arch Intern Med. 2006;166:498-504.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<ptr target="http://www.glowcaps.com/product/" />
		<title level="m" xml:id="_94gjCRt">Vitality GlowCap</title>
		<imprint>
			<date type="published" when="2016-08-11">August 11, 2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vitality GlowCap. http://www.glowcaps.com/product/. Accessed August 11, 2016.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_Zu8H7cg">Kidney transplantation in patients with HIV infection</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Reese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Blumberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Bloom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sGg99jh">Adv Chronic Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="94" to="101" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Reese PP, Blumberg EA, Bloom RD. Kidney trans- plantation in patients with HIV infection. Adv Chronic Kidney Dis. 2010;17:94-101.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_uFGEbwF">On the Way to Health</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mKmkKHD">LDI Issue Brief</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1" to="4" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Asch DA, Volpp KG. On the Way to Health. LDI Issue Brief. 2012;17:1-4.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_mc9Tdkb">Quantitative patterns of azathioprine adherence after renal transplantation</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Nevins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Thomas</surname></persName>
		</author>
		<idno type="DOI">10.1097/tp.0b013e318195c3d5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eWYeD3x">Transplantation</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="711" to="718" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nevins TE, Thomas W. Quantitative patterns of azathio- prine adherence after renal transplantation. Transplantation. 2009;87:711-718.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_GNBBQra">Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review</title>
		<author>
			<persName><forename type="first">K</forename><surname>Denhaerynck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Dobbels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Cleemput</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HnbKFt2">Transpl Int</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1121" to="1133" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of nonadherence in adult renal trans- plant patients: a literature review. Transpl Int. 2005;18:1121-1133.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_UMyMMvH">Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients</title>
		<author>
			<persName><forename type="first">S</forename><surname>Christina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Annunziato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Schiano</surname></persName>
		</author>
		<idno type="DOI">10.1002/lt.23930</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EVqfSSh">Liver Transpl</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1168" to="1177" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Christina S, Annunziato RA, Schiano TD, et al. Medication level variability index predicts rejection, possibly due to non- adherence, in adult liver transplant recipients. Liver Transpl. 2014;20:1168-1177.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_SAx2MhH">An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Venkat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Nick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Bucuvalas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MAUHhyv">Pediatr Transplant</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="67" to="72" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Venkat VL, Nick TG, Wang Y, Bucuvalas JC. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence. Pediatr Trans- plant. 2008;12:67-72.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_3NkWcMc">Timedependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sapir-Pichhadze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Famure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1038/ki.2013.465</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nr5gcZC">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="1404" to="1411" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sapir-Pichhadze R, Wang Y, Famure O, Li Y, Kim SJ. Time- dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure. Kidney Int. 2014;85:1404-1411.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_ew4F2t3">The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review</title>
		<author>
			<persName><forename type="first">F</forename><surname>Dobbels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Berben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Geest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<idno type="DOI">10.1097/tp.0b013e3181e346cd</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_F9ZawYt">Transplantation</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="205" to="219" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dobbels F, Berben L, De Geest S, et al. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation. 2010;90:205-219.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_f2BuzAf">The Multidimensional Scale of Perceived Social Support</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Zimet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Dahlem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Zimet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Farley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vPhfgkh">J Pers Assess</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="30" to="41" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support. J Pers Assess. 1988;52:30-41.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_StzeTRk">Psychometric characteristics of the Multidimensional Scale of Perceived Social Support</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Zimet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Powell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Farley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Werkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Berkoff</surname></persName>
		</author>
		<idno type="DOI">10.1207/s15327752jpa5503&amp;4_17</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5kvWMAJ">J Pers Assess</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="610" to="617" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA. Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess. 1990;55:610-617.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<monogr>
		<title level="m" type="main" xml:id="_NEQe8gJ">Adherence to Long-term Therapies: Evidence for Action</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sabate</surname></persName>
		</author>
		<idno type="DOI">10.26719/2015.21.6.379</idno>
		<imprint>
			<date type="published" when="2003">2003</date>
			<publisher>World Health Organization</publisher>
			<pubPlace>Geneva, Switzerland</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Sabate E. Adherence to Long-term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_tXt4TYc">Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Pinsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Takemoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Lentine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Burroughs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Schnitzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Salvalaggio</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-6143.2009.02798.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_f3mnMHe">Am J Transplant</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="2597" to="2606" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Transplant outcomes and economic costs associated with patient noncompliance to immu- nosuppression. Am J Transplant. 2009;9:2597-2606.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<author>
			<persName><forename type="first">B</forename><surname>Efron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Tibshirani</surname></persName>
		</author>
		<title level="m" xml:id="_YdDWnSM">An Introduction to the Bootstrap</title>
		<meeting><address><addrLine>New York, NY</addrLine></address></meeting>
		<imprint>
			<publisher>Chapman &amp; Hall</publisher>
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman &amp; Hall; 1993.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<monogr>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Davison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">V</forename><surname>Hinkley</surname></persName>
		</author>
		<idno type="DOI">10.1017/cbo9780511802843</idno>
		<title level="m" xml:id="_hvZrtFM">Bootstrap Methods and Their Application</title>
		<meeting><address><addrLine>Cambridge, UK</addrLine></address></meeting>
		<imprint>
			<publisher>Cambridge University Press</publisher>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Davison AC, Hinkley DV. Bootstrap Methods and Their Application. Cambridge, UK: Cambridge University Press; 1997.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_rdWCdm7">Adherence with statin therapy in elderly patients with and without acute coronary syndromes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Jackevicius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mamdani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Tu</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.288.4.462</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_58sEznY">JAMA</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="page" from="462" to="467" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syn- dromes. JAMA. 2002;288:462-467.</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_57MXaUx">Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study</title>
		<author>
			<persName><forename type="first">S</forename><surname>De Geest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Burkhalter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bogert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RvbK4Yc">Transpl Int</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="657" to="666" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">De Geest S, Burkhalter H, Bogert L, et al. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study. Transpl Int. 2014;27:657-666.</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_CWCYXD6">Is calculating the standard deviation of tacrolimus blood levels the new gold standard for evaluating non-adherence to medications in transplant recipients?</title>
		<author>
			<persName><forename type="first">E</forename><surname>Shemesh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Fine</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1399-3046.2010.01396.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uGQFGHq">Pediatr Transplant</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="940" to="943" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shemesh E, Fine RN. Is calculating the standard deviation of tacrolimus blood levels the new gold standard for evaluating non-adherence to medications in transplant recipients? Pediatr Transplant. 2010;14:940-943.</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_Hhr3SUd">Wearable devices as facilitators, not drivers, of health behavior change</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_k9ykNJk">JAMA</title>
		<imprint>
			<biblScope unit="volume">313</biblScope>
			<biblScope unit="page" from="459" to="460" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Patel MS, Asch DA, Volpp KG. Wearable devices as fa- cilitators, not drivers, of health behavior change. JAMA. 2015;313: 459-460.</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_ebc6ukv">Adherence to medication</title>
		<author>
			<persName><forename type="first">L</forename><surname>Osterberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Blaschke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_x6MAQvK">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">353</biblScope>
			<biblScope unit="page" from="487" to="497" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.</note>
</biblStruct>

<biblStruct xml:id="b49">
	<monogr>
		<title level="m" type="main" xml:id="_DqU4EMs">Health Behavior and Health Education: Theory, Research, and Practice</title>
		<author>
			<persName><forename type="first">K</forename><surname>Glanz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Rimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Viswanath</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2008">2008</date>
			<publisher>Jossey-Bass</publisher>
			<pubPlace>Hoboken, NJ</pubPlace>
		</imprint>
	</monogr>
	<note>5th ed</note>
	<note type="raw_reference">Glanz K, Rimer BK, Viswanath K. Health Behavior and Health Education: Theory, Research, and Practice. 5th ed. Hoboken, NJ: Jossey-Bass; 2008.</note>
</biblStruct>

<biblStruct xml:id="b50">
	<monogr>
		<author>
			<persName><surname>Adheretech</surname></persName>
		</author>
		<ptr target="https://www.adheretech.com/" />
		<title level="m" xml:id="_v8cYyrf">Smart wireless pill bottles improve and track adherence in real-time</title>
		<imprint>
			<date type="published" when="2016-08-11">August 11, 2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Adheretech. Smart wireless pill bottles improve and track adherence in real-time. https://www.adheretech.com/. Accessed August 11, 2016.</note>
</biblStruct>

<biblStruct xml:id="b51">
	<monogr>
		<author>
			<persName><surname>Clevercap</surname></persName>
		</author>
		<ptr target="https://ssl.clevercap.org/arc/about.html" />
		<title level="m" xml:id="_SMfapJK">The perfect prescription for medication adherence</title>
		<imprint>
			<date type="published" when="2016-08-11">August 11, 2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Clevercap. The perfect prescription for medication adher- ence. https://ssl.clevercap.org/arc/about.html. Accessed August 11, 2016.</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_vvZFjgb">Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Wolfe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">B</forename><surname>Ashby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Milford</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejm199912023412303</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7ABpVj5">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">341</biblScope>
			<biblScope unit="page" from="1725" to="1730" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725-1730.</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_79WEuHS">Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities</title>
		<author>
			<persName><forename type="first">G</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Chapman</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0029591</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yHZePjU">PloS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e29591</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wong G, Howard K, Chapman JR, et al. Comparative sur- vival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PloS One. 2012;7:e29591.</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_2rxPgSw">Peer mentoring and financial incentives to improve glucose control in African American veterans: a randomized trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Long</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Jahnle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Richardson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Loewenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8gvSpBx">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="416" to="424" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Long JA, Jahnle EC, Richardson DM, Loewenstein G, Volpp KG. Peer mentoring and financial incentives to improve glucose control in African American veterans: a randomized trial. Ann Intern Med. 2012;156:416-424.</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_bFkvg74">A test of financial incentives to improve warfarin adherence</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Loewenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Troxel</surname></persName>
		</author>
		<idno type="DOI">10.1186/1472-6963-8-272</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SgPZuJu">BMC Health Serv Res</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">272</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Volpp KG, Loewenstein G, Troxel AB, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008;8:272.</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_7b9xvze">Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Kurian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gelbart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JVhjE26">Am J Transplant</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1164" to="1172" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kurian SM, Williams AN, Gelbart T, et al. Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling. Am J Transplant. 2014;14:1164-1172.</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_d9qvMUM">Urinary-cell mRNA profile and acute cellular rejection in kidney allografts</title>
		<author>
			<persName><forename type="first">M</forename><surname>Suthanthiran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ding</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_m8v3UGq">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page" from="20" to="31" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Suthanthiran M, Schwartz JE, Ding R, et al. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med. 2013;369:20-31.</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_Zp9Ywms">Influence of pill burden and drug cost on renal function after transplantation</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Hardinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hutcherson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Preston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Murillo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AUkS8mF">Pharmacotherapy</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="427" to="432" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hardinger KL, Hutcherson T, Preston D, Murillo D. In- fluence of pill burden and drug cost on renal function after transplantation. Pharmacotherapy. 2012;32:427-432.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
